Skip to main content
. 2023 Mar 27;13(5):e2979. doi: 10.1002/brb3.2979

FIGURE 2.

FIGURE 2

Association of serum lipocalin‐2 (LCN2) levels with risk of early neurological deterioration (END) (A) and 90‐day unfavorable outcome (B). Odds ratios and 95% confidence intervals were derived from restricted cubic spline regression, with knots placed at the 5th, 50th, and 95th percentiles of the distribution of LCN2. The reference point for serum LCN2 is the midpoint of the reference group from the categorical analysis. Odds ratios were adjusted for age, sex, and variables with a p value <.1 in the univariate analysis.